After multiple treatment failures, genomic analyses of tissue and liquid biopsies revealed dynamic changes in tumor biology and the emergence of resistance mechanisms, particularly AR amplification, identified with a liquid biopsy test and validated by [<sup>18</sup>F]-FDHT PET scan. This evidence concerns the gene AR and neoplasm.